Author

Irene Carrozzo

University of BernORCID 0009-0005-8152-757XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:CRISPR screen· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Adrian F. OchsenbeiniD· 1 shared Adrienne VancuraiD· 1 shared Alessandro UmbachiD· 1 shared Álvaro AndradesiD· 1 shared Andrea Kobel· 1 shared Andrés LanzósiD· 1 shared Anna CeresetoiD· 1 shared Carlos Pulido-QuetglasiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Adrian F. OchsenbeinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringMolecular TherapyPeer-reviewedJan 9, 2025

Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing

Irene Carrozzo, Giulia Maule, Carmelo Gentile…·Anna Cereseto

This study uses CRISPR base editing to introduce revertant mutations in F508del-CFTR, rescuing protein folding and function in CF patient-derived cells.

6 citations

humangenetic perturbation / CRISPR

𝕏 PostBluesky

GenomicsCell GenomicsPeer-reviewedAug 22, 2022

Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities

Roberta Esposito, Taisia Polidori, Dominik F. Meise…·Rory Johnson

The paper identifies 60 high-confidence oncogenic lncRNAs in NSCLC using CRISPR deletion screens and ASO validation, revealing therapeutic vulnerabilities.

35 citations

humanCRISPR screen

𝕏 PostBluesky